Literature DB >> 34259492

Reducing Prenatal Exposure to Toxic Environmental Agents: ACOG Committee Opinion, Number 832.

.   

Abstract

ABSTRACT: There is emerging evidence that links exposure to toxic environmental agents and adverse reproductive and developmental health outcomes. Toxic exposures related to reproductive and developmental health primarily have been associated with infertility and miscarriage, obstetric outcomes such as preterm birth and low birth weight, neurodevelopmental delay such as autism and attention deficit hyperactivity disorder, and adult and childhood cancer. Although there is substantial overlap in the type of exposure and the associated health outcomes, for the purposes of this document, exposures generally can be grouped into the following categories: toxic chemicals, air pollution, and climate change-related exposures. Obstetric care clinicians do not need to be experts in environmental health science to provide useful information to patients and refer patients to appropriate specialists, if needed, when a hazardous exposure is identified. It is important for obstetrician-gynecologists and other obstetric care clinicians to become knowledgeable about toxic environmental exposures that are endemic to their specific geographic areas, such as local water safety advisories (eg, lead-contaminated water), local air quality levels, and patients' proximity to power plants and fracking sites. Although exposure to toxic environmental agents is widespread across populations, many environmental factors that are harmful to reproductive health disproportionately affect underserved populations and are subsumed in issues of environmental justice. Clinical encounters offer an opportunity to screen and counsel patients during the prepregnancy and prenatal periods-particularly individuals most disproportionately affected-about opportunities to reduce toxic environmental health exposures. This Committee Opinion is revised to integrate more recent literature regarding reducing prepregnancy and prenatal toxic environmental exposures.
Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34259492     DOI: 10.1097/AOG.0000000000004449

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Maternal perfluorooctane sulfonic acid exposure during rat pregnancy causes hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in the uterine arteries †.

Authors:  Sri Vidya Dangudubiyyam; Jay S Mishra; Ruolin Song; Sathish Kumar
Journal:  Biol Reprod       Date:  2022-10-11       Impact factor: 4.161

2.  Development and Validation of the Prevention of Toxic Chemicals in the Environment for Children Tool: A Questionnaire for Examining the Community's Knowledge of and Preferences Toward Toxic Chemicals and Children's Brain Development.

Authors:  Rivka Green; Bruce Lanphear; Erica Phipps; Carly Goodman; Jasmine Joy; Samer Rihani; David Flora; Christine Till
Journal:  Front Public Health       Date:  2022-05-11

3.  Making obstetrics more environmentally sustainable during and beyond the COVID-19 pandemic.

Authors:  Anna Eleftheriades; Christos Tsagkaris; Yakup Gozderesi; Periklis Panagopoulos
Journal:  Int J Health Plann Manage       Date:  2022-05-07

Review 4.  Nutritional interventions to ameliorate the effect of endocrine disruptors on human reproductive health: A semi-structured review from FIGO.

Authors:  Gillian A Corbett; Sadhbh Lee; Tracey J Woodruff; Mark Hanson; Moshe Hod; Anne Marie Charlesworth; Linda Giudice; Jeanne Conry; Fionnuala M McAuliffe
Journal:  Int J Gynaecol Obstet       Date:  2022-02-23       Impact factor: 4.447

5.  Knowledge, Attitudes, and Behaviors Regarding Chemical Exposure among a Population Sample of Reproductive-Aged Women.

Authors:  Isabel J Ricke; Ashley Oglesby; Grace R Lyden; Emily S Barrett; Stacey Moe; Ruby H N Nguyen
Journal:  Int J Environ Res Public Health       Date:  2022-03-04       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.